Bryan Wahl
General Counsel
Tarsus Pharmaceuticals, Inc. (TARS)Equibles does not estimate personal net worth.
Get an email with a short summary when Tarsus Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get TARS alertsAbout Bryan Wahl
Bryan Wahl is recorded as General Counsel at Tarsus Pharmaceuticals, Inc. (TARS). The newest filing on record that lists Bryan Wahl as General Counsel at Tarsus Pharmaceuticals, Inc. (TARS) is dated April 28, 2026. The proxy statement of Tarsus Pharmaceuticals, Inc. reports total compensation of $2,560,205 for Bryan Wahl in fiscal 2025, including a base salary of $500,833. Disclosed compensation is on record for 3 fiscal years. Tarsus Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tarsus Pharmaceuticals, Inc. includes Bobak Azamian (CEO and Chairman), Jeffrey S. Farrow (CFO), Leonard Greenstein (CFO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 28, 2026
Company network
Leadership on record at Tarsus Pharmaceuticals, Inc.
- Bobak Azamian CEO, Chairman
- Jeffrey S. Farrow CFO
- Leonard Greenstein CFO
- Seshadri Neervannan COO
- Andrew Goldberg Board Member
- Bhaskar Chaudhuri Board Member
- David E.I. Pyott Board Member
- Elizabeth Yeu-Lin, M.D. Board Member
- Katherine Goodrich Board Member
- Rosemary A. Crane Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | M.D., J.D. General Counsel | $500,833 | $2,560,205 |
| 2022 | Tarsus Pharmaceuticals, Inc. (TARS) | M.D., J.D. General Counsel and Secretary | $420,000 | $2,534,349 |
| 2021 | Tarsus Pharmaceuticals, Inc. (TARS) | M.D., J.D. General Counsel and Secretary | $345,000 | $2,626,942 |
Recent activity
No call appearances or filed executive changes recorded yet.